169 related articles for article (PubMed ID: 32992320)
1. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
[TBL] [Abstract][Full Text] [Related]
3. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
[TBL] [Abstract][Full Text] [Related]
5. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
[TBL] [Abstract][Full Text] [Related]
6. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan.
Hsu MH; Wang WL; Chen TH; Tai CM; Wang HP; Lee CT
BMC Gastroenterol; 2021 Aug; 21(1):308. PubMed ID: 34344303
[TBL] [Abstract][Full Text] [Related]
8. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation.
Ogasawara N; Kikuchi D; Inoshita N; Nakayama A; Kohno K; Ochiai Y; Hayasaka J; Suzuki Y; Dan N; Okamura T; Mitsunaga Y; Tanaka M; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S; Iizuka T
Esophagus; 2021 Oct; 18(4):806-816. PubMed ID: 33974189
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Kim GH; Min YW; Lee H; Min BH; Lee JH; Rhee PL; Kim JJ
PLoS One; 2020; 15(9):e0238113. PubMed ID: 32886924
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.
Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Watanabe S; Seri S; Asato A; Shiozaki A; Fujiwara H; Konishi H; Dohi O; Ishikawa T; Elsaleh H; Yamada K
Radiat Oncol; 2022 Nov; 17(1):191. PubMed ID: 36401267
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
[TBL] [Abstract][Full Text] [Related]
12. Metachronous multiple esophageal squamous cell carcinomas and Lugol-voiding lesions after endoscopic mucosal resection.
Urabe Y; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
Endoscopy; 2009 Apr; 41(4):304-9. PubMed ID: 19340732
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
[TBL] [Abstract][Full Text] [Related]
14. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
Ogasawara N; Kikuchi D; Tanaka M; Ochiai Y; Okamura T; Hayasaka J; Suzuki Y; Mitsunaga Y; Nomura K; Odagiri H; Yamashita S; Matsui A; Hoteya S
Esophagus; 2022 Jul; 19(3):460-468. PubMed ID: 35099639
[TBL] [Abstract][Full Text] [Related]
16. The Alcohol Use Disorders Identification Test and the risk of metachronous cancer after endoscopic resection of esophageal cancer.
Yokoyama A; Katada C; Yokoyama T; Takizawa K; Yano T; Oda I; Shimizu Y; Nakanishi H; Koike T; Hirao M; Okada H; Yoshii T; Katagiri A; Yamanouchi T; Matsuo Y; Kawakubo H; Kobayashi N; Ishikawa H; Muto M
Carcinogenesis; 2020 Aug; 41(8):1049-1056. PubMed ID: 32157279
[TBL] [Abstract][Full Text] [Related]
17. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis.
Li J; Wang L; Shi X; Chen J; Jin Z; Zou D; Li Z; Liu F
Surg Endosc; 2023 Mar; 37(3):1761-1770. PubMed ID: 36220991
[TBL] [Abstract][Full Text] [Related]
19. Effect of chemoradiation on the development of second primary cancers after endoscopic resection of T1 esophageal squamous cell carcinoma.
Yoshio T; Minashi K; Mizusawa J; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Yano T; Takizawa K; Fukuda H; Muto M
Esophagus; 2022 Jul; 19(3):469-476. PubMed ID: 35320430
[TBL] [Abstract][Full Text] [Related]
20. Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy.
Kanie Y; Okamura A; Asari T; Maruyama S; Sakamoto K; Fujiwara D; Kanamori J; Imamura Y; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8428-8435. PubMed ID: 34085140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
